---
title: "45 Medtech Investors in Europe (Nov 2026): Top 10 Ranked"
last_updated: "2026-11-09"
rows: "45"
free_rows: "22"
source: "Official registers and each organization's own website"
canonical: "https://theinvestordatabase.com/lists/medtech-investors-europe/"
---

# 45 medtech investors in Europe

We list 45 medtech investors in Europe as of November 2026: each was checked on its own website or an official register, and the list was last checked on 9 Nov 2026. The cities with the most head offices on this list are Paris (7), Dublin (3) and Munich (3).

- 45 investors
- 25 with a fund filing or dated deal in the last 12 months
- 142 named decision-makers on file

## First 22 of 45 medtech investors in Europe

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| HBM Partners | Fund manager | Zug, Switzerland | Series A, Series B, Growth, Late stage | Medtech, Healthtech, Biotech | Portfolio news, Oct 2026 | $2.8B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/hbm-partners-ag/ |
| Andera Partners | Fund manager | Paris, France | Seed, Series A, Series B, Growth | Medtech, Biotech, Healthtech, Generalist | Portfolio news, Sep 2026 | €6.0B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/andera-partners/ |
| Truffle Capital | VC firm | Paris, France |  | Medtech, Healthtech, Biotech, Fintech | Portfolio news, Oct 2026 | €500M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/truffle-capital/ |
| Fountain Healthcare Partners | VC firm | Dublin, Ireland | Seed | Medtech, Healthtech, Biotech | Portfolio news, Oct 2026 | €425M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/fountain-healthcare-partners/ |
| NLC Health Ventures | VC firm | Amsterdam, Netherlands | Pre-seed, Seed | Medtech, Healthtech, Biotech | New fund, Sep 2026 | €300M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/nlc-fund-management-b-v/ |
| Hadean Ventures | VC firm | Norway | Seed, Series A, Series B | Medtech, Healthtech, Biotech | New deal, Sep 2026 | €230M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/hadean-ventures-as/ |
| Angelor | VC firm | Lyon, France | Seed, Series A | Medtech, Healthtech, Biotech, Food and Beverage | New deal, Sep 2026 | €100M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/angelor/ |
| 819 Capital Partners | VC firm | Deventer, Netherlands | Seed, Series A, Growth | Medtech, Healthtech, Biotech, Generalist | Portfolio news, Sep 2026 | €100M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/819-capital-partners/ |
| Lauxera Capital Partners | VC firm | Paris, France | Growth | Medtech, Healthtech | New fund, May 2026 | €800M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/lauxera-capital-partners/ |
| Wellington Partners | VC firm | Munich, Germany | Series A, Series B, Growth | Medtech, Healthtech, Biotech | Portfolio news, May 2026 | €210M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/wellington-partners/ |
| 415 Capital | VC firm | Munich, Germany | Series A, Series B, Growth | Medtech, Healthtech | Portfolio news, Nov 2026 |  | 2026-11-07 | https://theinvestordatabase.com/investors/415-capital-management-gmbh/ |
| CRB Health Tech | VC firm | Madrid, Spain | Seed, Series A | Medtech, Healthtech, Biotech | New fund, Oct 2026 |  | 2026-11-07 | https://theinvestordatabase.com/investors/crb-health-tech-s-g-e-i-c-s-a/ |
| TVM Capital Life Science | VC firm | Munich, Germany | Seed, Series A, Series B, Growth | Medtech, Healthtech, Biotech | Portfolio news, Sep 2026 |  | 2026-11-07 | https://theinvestordatabase.com/investors/tvm-capital-life-science/ |
| b2venture | VC firm | St. Gallen, Switzerland | Pre-seed, Seed, Series A | Medtech, AI, Fintech, Healthtech | Portfolio news, Oct 2026 |  | 2026-11-07 | https://theinvestordatabase.com/investors/b2venture-formerly-btov-partners/ |
| Gilde Healthcare | Fund manager | Utrecht, Netherlands | Series A, Series B, Growth | Medtech, Healthtech, Biotech, Climate Tech | New fund, Feb 2026 | €3.0B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/gilde-healthcare-partners-b-v/ |
| XGEN Venture | VC firm | Milan, Italy | Seed, Series A | Medtech, Healthtech, Biotech | Portfolio news, Oct 2026 |  | 2026-11-07 | https://theinvestordatabase.com/investors/xgen-venture-sgr-spa/ |
| TNO Ventures | Government or university fund | Netherlands | Pre-seed, Seed | Medtech, Deep Tech, AI, Climate Tech | Portfolio news, Sep 2026 |  | 2026-11-07 | https://theinvestordatabase.com/investors/tno-ventures-holding-b-v/ |
| SHS Capital | Fund manager | Tübingen, Germany | Growth | Medtech, Healthtech, Biotech | New fund, Feb 2026 | €270M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/shs-gesellschaft-fur-beteiligungsmanagement-mbh/ |
| Mérieux Equity Partners | Fund manager | Lyon, France | Seed, Series A, Series B | Medtech, Healthtech, Biotech | Investment listed in 2026 | €150M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/merieux-equity-partners/ |
| Curie Capital | VC firm | Amstelveen, Netherlands | Seed, Series A | Medtech, Healthtech, Biotech | Portfolio news, Jun 2026 |  | 2026-11-07 | https://theinvestordatabase.com/investors/curie-capital/ |
| Asabys Partners | VC firm | Barcelona, Spain |  | Medtech, Healthtech, Biotech | New fund, Jul 2026 |  | 2026-11-07 | https://theinvestordatabase.com/investors/asabys-partners-sgeic-s-a/ |
| Segulah Medical Acceleration (SMA) | VC firm | Stockholm, Sweden | Series A, Growth | Medtech, Healthtech | Portfolio news, Jun 2025 | €120M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/segulah-medical-acceleration/ |

You are seeing 22 of 45. The full list adds 23 more investors and 142 named decision-makers.

Get all 45 investors and 142 named contacts, $49, one-time: https://theinvestordatabase.com/buy/list/medtech-investors-europe
This page: https://theinvestordatabase.com/lists/medtech-investors-europe/

## Method and limits
- Source: No row on this list rests on an SEC filing. All 45 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states medtech and medical devices as a focus on its own site, or we observed it in the firm's portfolio.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (40: within 3 months 40, 6 months 30, 12 months 20, 24 months 10), share of the observed portfolio in this sector (30; 15 when the sector is stated only), size of the fund on file on a log scale (20) and completeness of the public record (10). It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 45 rows: stage 40, sector 45, fund size 19, website 45. In the paid file: named decision-makers on 39 rows, firm email on 37, LinkedIn page on 33, check size on 14.

## Questions
### How many medtech investors in Europe are there?
We list 45 as of November 2026. 25 of the 45 have a fund filing or a dated deal in the last 12 months. The cities with the most are Paris (7), Dublin (3) and Munich (3).

### Which medtech investors in Europe raised a new fund in the last 12 months?
None of the 45 has a fund filing dated in the last 12 months on file; 25 have other dated activity in that time (fund announcement, new deal and portfolio news), most recently 415 Capital (portfolio news, Nov 2026), HBM Partners (portfolio news, Oct 2026) and XGEN Venture (portfolio news, Oct 2026).

### What is the typical fund size of medtech investors in Europe?
None of the 45 discloses a fund size on an SEC Form D, so there is no median to give. 19 rows carry a size or assets figure from another public source, for example HBM Partners at $2.8B (own site) and Andera Partners at €6.0B (own site).

### Which stage do most medtech investors in Europe back?
Of the 40 with a stage on file, seed (28), Series A (24) and growth-stage (19). A firm can back more than one stage, and 5 rows have no stage on file yet.

### Where does the data on medtech investors in Europe come from and how often is it updated?
All 45 rows were checked on the firm's own website, with official registers and national venture capital association directories as the starting point. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.

### Can I download the list of medtech investors in Europe as a spreadsheet?
Yes. The file holds all 45 rows in Excel and CSV, with 142 named decision-makers and 37 firm emails, for $49 one-time. 22 rows are free on this page.